TY - JOUR
T1 - Diversity in pediatric dermatology
T2 - A report from the Pediatric Dermatology Research Alliance and a call to action
AU - Davies, Olivia M.T.
AU - Benjamin, Latanya
AU - Gupta, Deepti
AU - Huang, Jennifer T.
AU - Rehmus, Wingfield
AU - Siegel, Dawn H.
AU - Siegel, Michael P.
N1 - Funding Information:
At least one EDI‐focused grant has been funded annually since 2017 (14.2% of PeDRA’s annual research support from 2017 to 2020). During the writing of this manuscript, two additional EDI‐focused research fellowships were awarded, bringing the current investment by PeDRA in EDI research projects from 2017 to 2021 to $162 500 (full details on project titles and co‐sponsored grants found in Table 2 ). Continued efforts from the PeDRA EDI Task Force should focus on continuing to identify important EDI research projects to advance URM research for pediatric skin disease. Approximately 12.5% (6/48 reported) of PeDRA’s studies have been led by a URM PI; however, it is important to note that no Black/African American individuals have applied to serve as PI for a PeDRA study. Efforts to support the career development of PeDRA’s growing URM membership could serve to increase the number of URM study applications and PIs. A majority (91.4%) of PeDRA’s grants and research fellowships have gone to White or Asian/Pacific Islander individuals who make up nearly 85% of PeDRA’s current membership. Importantly, no Black/African American individuals have been awarded research fellowship awards. This may be the product of a lack of URM‐focused research pipeline infrastructure to prepare URM trainees for early career research applications.
Funding Information:
Dr Latanya Benjamin is an author for UpToDate and a speaker for Pfizer, Sanofi Genzyme. Dr Deepti Gupta is an author for UpToDate. Dr Dawn Siegel is an author for UpToDate, a consultant for Arqule and Merck and has received a research grant from SID‐SUN. Dr Jennifer Huang is a Scientific Advisor for EllaOla. Dr Wingfield Rehmus is an author for Merck Manual and a consultant/speaker for Pfizer, Sanofi Genzyme, Leo Pharmaceuticals, Abbvie. Dr Michael Siegel is employed by the Pediatric Dermatology Research Alliance. Dr Olivia Davies served for two years as the Pediatric Dermatology Research Alliance Fellow.
Publisher Copyright:
© 2021 Wiley Periodicals LLC.
PY - 2021/11
Y1 - 2021/11
N2 - Background/Objectives: The Pediatric Dermatology Research Alliance (PeDRA) connects pediatric dermatologists, trainees, basic scientists, allied health professionals, and patient advocates to improve the lives of children with skin disease through research. As a training pipeline for future pediatric dermatologists and steward of research in the field, PeDRA has a responsibility to examine its history and take actionable steps to diversify its membership, grant recipients, study leads, research priorities, and leadership. Methods: In 2020, PeDRA formed an Equity, Diversity, and Inclusion Task Force to address this need. In an effort to assess PeDRA’s past and plan for PeDRA’s future, a review of PeDRA’s membership, leadership, grant awardees, and research topics was conducted. Results/Conclusions: Results demonstrated gaps in PeDRA’s current operational efforts to diversify the pediatric dermatology workforce and identified areas for improvement. Recommendations are proposed as a call to action for the community.
AB - Background/Objectives: The Pediatric Dermatology Research Alliance (PeDRA) connects pediatric dermatologists, trainees, basic scientists, allied health professionals, and patient advocates to improve the lives of children with skin disease through research. As a training pipeline for future pediatric dermatologists and steward of research in the field, PeDRA has a responsibility to examine its history and take actionable steps to diversify its membership, grant recipients, study leads, research priorities, and leadership. Methods: In 2020, PeDRA formed an Equity, Diversity, and Inclusion Task Force to address this need. In an effort to assess PeDRA’s past and plan for PeDRA’s future, a review of PeDRA’s membership, leadership, grant awardees, and research topics was conducted. Results/Conclusions: Results demonstrated gaps in PeDRA’s current operational efforts to diversify the pediatric dermatology workforce and identified areas for improvement. Recommendations are proposed as a call to action for the community.
KW - URM
KW - diversity
KW - equity
KW - inclusion
KW - pediatric dermatology
UR - http://www.scopus.com/inward/record.url?scp=85112767570&partnerID=8YFLogxK
U2 - 10.1111/pde.14756
DO - 10.1111/pde.14756
M3 - Article
AN - SCOPUS:85112767570
VL - 38
SP - 96
EP - 102
JO - Pediatric Dermatology
JF - Pediatric Dermatology
SN - 0736-8046
IS - S2
ER -